Reference

ADHD medications in the US

A guide to the ADHD medications prescribed in the United States that ADHDose supports. There are three drug classes: amphetamine-based stimulants, methylphenidate-based stimulants, and non-stimulants. Each works differently, lasts a different amount of time, and interacts with your day in a different way. ADHDose models stimulant concentration curves in real time and tracks daily patterns for non-stimulants.

Stimulants vs non-stimulants

Stimulant medications work by directly increasing dopamine and norepinephrine in the brain. They take effect within hours of the first dose, and you can usually tell within the first day or two whether a stimulant is doing something. They have a daily rise-and-fall cycle: the medication builds, peaks, and wears off.

Non-stimulant medications work through different mechanisms and take weeks to reach full effect. They provide continuous, around-the-clock coverage without a daily peak-and-trough cycle. The trade-off is that you do not get an immediate signal of whether the medication is working. Tracking daily patterns over weeks is how you and your prescriber determine whether a non-stimulant is effective.

Most adults start with a stimulant (the FDA-approved first-line treatment for ADHD). Non-stimulants are typically considered when stimulants are ineffective, cause intolerable side effects, or are clinically unsuitable. ADHDose supports both classes.

Amphetamine-based medications

These medications are based on amphetamine salts. They increase both dopamine and norepinephrine. Three formulations are supported in ADHDose:

Vyvanse (lisdexamfetamine)

Long-acting · Prodrug · 10-14 hours · Once daily

Vyvanse is a prodrug that your body converts into dextroamphetamine gradually. This produces a smooth, sustained effect from a single morning dose. It is one of the most widely prescribed long-acting ADHD stimulants in the US. Known as Elvanse in the UK and Venvanse in the EU.

Read the full Vyvanse guide →

Adderall XR (mixed amphetamine salts, extended-release)

Long-acting · Two-phase bead system · 10-12 hours · Once daily

Adderall XR contains a mixture of four amphetamine salts (75% dextroamphetamine, 25% levoamphetamine) in a two-phase bead system. Half the dose releases immediately, the rest releases approximately 4 hours later. This produces two distinct peaks of activity through the day.

Read the full Adderall XR guide →

Adderall IR (mixed amphetamine salts, immediate-release)

Short-acting · Immediate-release · 4-6 hours · 2-3 times daily

Adderall IR delivers the same mixed amphetamine salts as Adderall XR but as a single immediate release. Each dose lasts 4 to 6 hours. It is taken multiple times daily and is also commonly used as a booster alongside long-acting formulations.

Read the full Adderall guide →

Methylphenidate-based medications

These medications block the reuptake of dopamine and norepinephrine. ADHDose supports one US-specific methylphenidate formulation:

Focalin XR (dexmethylphenidate, extended-release)

Long-acting · Two-phase bead system · 8-12 hours · Once daily

Focalin XR contains dexmethylphenidate, the more pharmacologically active isomer of methylphenidate. Because it uses only the active form, Focalin XR achieves equivalent effectiveness at roughly half the milligram dose of racemic methylphenidate formulations like Concerta or Ritalin.

Read the full Focalin XR guide →

Note: Concerta (methylphenidate OROS) and Ritalin (methylphenidate IR) are also available in the US. ADHDose supports both. See the Concerta guide and Ritalin guide for details.

Non-stimulant medications

Non-stimulants take weeks to reach full effect. They provide 24-hour coverage without a daily peak and wear-off cycle. ADHDose does not model a daily concentration curve for non-stimulants (there is no meaningful daily peak to visualise). Instead, it tracks your daily focus, mood, sleep, and side effects over the weeks it takes to reach full therapeutic effect.

Qelbree (viloxazine, extended-release)

Non-stimulant · NRI + serotonergic · 24-hour coverage · Once daily

Qelbree is a selective norepinephrine reuptake inhibitor with additional serotonergic activity. FDA-approved for adults in 2021. It reaches full effect in approximately 2 to 4 weeks. Currently available only in the US.

Read the full Qelbree guide →

Strattera / atomoxetine

Non-stimulant · NRI · 24-hour coverage · Once daily

Atomoxetine (brand name Strattera) is a selective norepinephrine reuptake inhibitor that provides continuous coverage. It reaches full effect in approximately 4 to 6 weeks. Available in the US, UK, and EU.

Read the full atomoxetine guide →

Quick reference

MedicationTypeOnsetDurationDaily doses
VyvanseStimulant (amphetamine prodrug)1-2h10-14h1
Adderall XRStimulant (mixed amphetamine salts)30-60m10-12h1
Adderall IRStimulant (mixed amphetamine salts)30-60m4-6h2-3
Focalin XRStimulant (dexmethylphenidate)~30m8-12h1
QelbreeNon-stimulant (NRI + serotonergic)Weeks24h1
StratteraNon-stimulant (NRI)Weeks24h1

Looking for UK medications? See the UK ADHD medications guide, which covers Elvanse, Concerta XL, Ritalin, Medikinet, and Dexamfetamine.

Track your medication with ADHDose

ADHDose models your concentration curve in real time for stimulants and tracks daily patterns for non-stimulants. See what your medication is actually doing.

Download free →

Android 8.0+ · iOS 15+ · Pro from $4.99/month

This page is for informational purposes only. ADHDose is not a medical device and does not provide medical advice, diagnosis, or treatment. Always consult your prescribing doctor or specialist before making changes to your medication. Contact: [email protected]